The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?
Lelliott et al. Malar J (2015) 14:289
DOI 10.1186/s12936-015-0809-x
Open Access
REVIEW
The influence of host genetics
on erythrocytes and malaria infection: is there
therapeutic potential?
Patrick M Lelliott*, Brendan J McMorran, Simon J Foote and Gaetan Burgio
Abstract
As parasites, Plasmodium species depend upon their host for survival. During the blood stage of their life-cycle parasites invade and reside within erythrocytes, commandeering host proteins and resources towards their own ends, and
dramatically transforming the host cell. Parasites aptly avoid immune detection by minimizing the exposure of parasite proteins and removing themselves from circulation through cytoadherence. Erythrocytic disorders brought on by
host genetic mutations can interfere with one or more of these processes, thereby providing a measure of protection
against malaria to the host. This review summarizes recent findings regarding the mechanistic aspects of this protection, as mediated through the parasites interaction with abnormal erythrocytes. These novel findings include the
reliance of the parasite on the host enzyme ferrochelatase, and the discovery of basigin and CD55 as obligate erythrocyte receptors for parasite invasion. The elucidation of these naturally occurring malaria resistance mechanisms is
increasing the understanding of the host-parasite interaction, and as discussed below, is providing new insights into
the development of therapies to prevent this disease.
Keywords: Malaria, Plasmodium, Host, Polymorphism, Erythrocyte, Red blood cell, Invasion, Growth, Cytoadherence,
Phagocytosis
Background
The clinical symptoms of malaria occur during the blood
stage of Plasmodium’s life cycle. Safely ensconced within
the host erythrocyte, parasites develop and replicate
whilst concealing their presence from the immune system. After consuming the contents of the host cell, and
growing and multiplying to fill the available space, the
progeny egress as merozoites, and, after briefly existing
extracellularly, invade fresh erythrocytes, continuing the
cycle of growth and proliferation. This cycle depends on
an elaborate interplay between host and parasite proteins,
which has been meticulously established over thousands
of years of co-evolution. As such, any perturbations to
the composition or arrangement of proteins in the host
erythrocyte can potentially impede the parasite’s growth
and survival, and thereby increase the resistance of the
*Correspondence:
John Curtin School of Medical Research, Australian National University,
Canberra, ACT, Australia
host to infection. Indeed, abnormalities of the erythrocyte are relatively common, especially in populations
residing in malaria-endemic regions, consistent with the
positive selection for these conditions. The mechanistic
basis for protection against malaria is partly understood
in some abnormalities; parasite invasion and intraerythrocytic development are often affected. However, recent
studies have revealed a more complex picture, with many
conditions sharing multiple and over-lapping pathways
that advantage the host. The understanding of the parasite-erythrocyte interaction is also being challenged as
novel and highly intimate relationships between the parasite and its host cell are discovered. This review will summarize the current knowledge regarding Plasmodium’s
interaction with abnormal host erythrocytes, the mechanisms by which these abnormalities can inhibit the blood
stage of Plasmodium’s life cycle, and the implications of
these findings for malaria treatment.
© 2015 Lelliott et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lelliott et al. Malar J (2015) 14:289
Genetic erythrocyte abnormalities and malaria
susceptibility
Erythrocytes have a limited lifespan (120 days in
humans) and, therefore, must be continually replenished
in a process known as erythropoiesis. In this process haematopoietic stem cells replicate and differentiate into
erythroblasts, and following expulsion of their nucleus
and most organelles, develop into reticulocytes. Reticulocytes are released from the bone marrow into the bloodstream and following further depletion of organelles and
intracellular RNA, become mature erythrocytes. There
are a number of erythrocyte disorders that result from
mutations in the genes expressed during erythropoiesis; many are highly prevalent, particularly in populations with a long history of malaria exposure. It was first
observed nearly 70 years ago that people with ‘sickled’
erythrocytes were less likely to suffer from malaria [1].
This condition is common in various West and Central African ethnicities. Now known as sickle cell trait,
this and many other erythrocytic disorders, have been
strongly associated with reduced malaria susceptibility.
In fact, mutations causing erythrocyte abnormalities are
the most commonly observed genetic traits in humans
[2]. Genetic mutations associated with malaria resistance
have been extensively reviewed previously [3–5]; a summary of known erythrocytic genetic disorders and their
association with malaria susceptibility is given in Table 1.
Mechanisms by which erythrocyte abnormalities
protect against malaria
Early studies towards identifying malaria protective mechanisms imparted by erythrocyte abnormalities largely
focussed on the ability of the parasite to invade and grow
within erythrocytes. These studies were facilitated by an
in vitro culturing system for Plasmodium falciparum,
which allowed researchers to easily compare between
erythrocytes obtained from subjects with various genetic
conditions. As the understanding of malaria pathogenesis
was expanded, the importance of factors such as cytoadherence and the ability of the immune system to detect
parasitized erythrocytes was also recognized. Studies then
addressed how erythrocyte abnormalities could affect
not only parasite invasion and growth under in vitro conditions, but also their effects in vivo, and how this may
influence host resistance to malaria infection. This review
considers how specific erythrocyte abnormalities affect
four distinct features of the parasite-host interaction.
Namely, merozoite invasion, parasite growth, cytoadherence, and erythrocyte senescence.
Merozoite invasion of the erythrocyte
The brief interval between parasite egress and reinvasion
of a new erythrocyte has long been considered a potential
Page 2 of 15
weak point in its blood stage lifecycle. In vitro studies
ha (...truncated)